# Renovia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/renovia

- Industry: Medical Devices & Equipment
- Headquarters: Boston, US
- Website: www.renoviainc.com
- Total disclosed funding: $49M
- Latest round: Series C (Apr 19, 2019)
- Investors on record: 8

## About

Renovia Inc. is a Boston-based company, established in 2016, focused on developing innovative digital health solutions to enhance women's pelvic health through advanced technology and personalized care.Renovia Inc. develops digital health solutions specifically designed for women's pelvic health. Founded in Boston, US in 2016 by Marc Beer, the company has engaged in four funding deals to date, with the latest being a Series C round in April 2019, raising USD 17.00 mn. The company's CEO is Eileen Maus.Renovia Inc. specializes in innovative digital health solutions aimed at improving women's pelvic health. Their product offerings include a suite of devices that empower patients through advanced technology and personalized care, focusing on urinary incontinence and pelvic floor disorders. The flagship product employs sensors and real-time feedback to guide users through tailored exercise programs, primarily targeting women in urban and suburban North America.Renovia Inc. generates revenue through a diversified transaction model, which includes direct sales of medical devices and subscription-based access to health monitoring applications. Their flagship products and digital services are priced to ensure accessibility while maintaining profitability through recurring subscriptions. Partnerships with healthcare providers and insurance companies further support customer access, creating a reliable revenue stream aligned with the company's mission to improve women's health.In April 2019, Renovia Inc. raised USD 17.00 mn in Series C funding to advance the commercial launch of their leva® Digital Therapeutic and support additional clinical development. The company aims to expand its product offerings and penetrate new markets, focusing on reaching more women across North America by enhancing awareness and accessibility to pelvic health solutions.

## Funding rounds

- Series C, Apr 19, 2019, $17M — Ascension Ventures, Longwood Fund, Perceptive Advisors, OSF Ventures, Parian Global Management
- Series B, Aug 21, 2018, $32M — Western Technology Investment, Ascension Ventures, Longwood Fund, Cormorant Asset Management, Perceptive Advisors, OSF Ventures, Inova Strategic Investments

## Investors

- Western Technology Investment (https://capitalatlas.ai/funds/western-technology-investment) — Series B
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series B, Series C
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series B, Series C
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series B
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series B, Series C
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series B, Series C
- Inova Strategic Investments (https://capitalatlas.ai/funds/inova-strategic-investments) — Series B
- Parian Global Management (https://capitalatlas.ai/funds/parian-global-management) — Series C